Effect of Nano-Hyaluronic Acid in Intrabony Defects Treated With Minimally Invasive Non-Surgical Technique
Clinical Evaluation of Nano-Hyaluronic Acid as an Adjunctive to Minimally Invasive Non-Surgical Technique in the Treatment of Deep Intrabony Defects: Randomized Controlled Clinical Trial
1 other identifier
interventional
28
1 country
1
Brief Summary
This randomized controlled clinical trial aims to evaluate the effectiveness of using nano-hyaluronic acid (nano-HyA) gel alongside a minimally invasive non-surgical technique (MINST) to treat deep intrabony defects in patients with Stage II and III periodontitis. While MINST is a proven method for cleaning deep periodontal pockets without the need for traditional surgery , the addition of nano-HyA may further enhance soft tissue healing, reduce inflammation, and promote regeneration. Participants in the study will be randomly assigned to one of two groups. The test group will receive the MINST procedure combined with the application of nano-HyA gel into the periodontal pocket, while the control group will receive the MINST procedure alone. The primary goal of the study is to measure the decrease in probing pocket depth over a 6-month follow-up period to determine if the adjunctive use of nano-HyA provides superior clinical and radiographic outcomes compared to non-surgical treatment alone
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2025
CompletedFirst Submitted
Initial submission to the registry
May 11, 2026
CompletedFirst Posted
Study publicly available on registry
May 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 29, 2026
May 19, 2026
May 1, 2026
1 year
May 11, 2026
May 15, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Pocket Depth (PD)
Measured in millimeters (mm) from the gingival margin to the bottom of the gingival sulcus using a UNC-15 periodontal probe. Each tooth is probed at 6 sites with a light force not exceeding 25 grams.
"From enrollment to the end of treatment at 24 weeks"
Secondary Outcomes (7)
Full-Mouth Plaque Score (FMPS)
From enrollment to the end of treatment at 24 weeks
Full-Mouth Bleeding Score (FMBS)
From enrollment to the end of treatment at 24 weeks
Clinical Attachment Level (CAL)
From enrollment to the end of treatment at 24 weeks
Gingival Recession (GR)
From enrollment to the end of treatment at 24 weeks
Radiographic Defect Angle (RDA)
From enrollment to the end of treatment at 24 weeks
- +2 more secondary outcomes
Study Arms (2)
MINST alone
ACTIVE COMPARATORParticipants receive the minimally invasive non-surgical technique (MINST) alone without adjunctive treatment
MINST + nano-hyaluronic acid
EXPERIMENTALParticipants receive MINST combined with adjunctive nano-hyaluronic acid
Interventions
Subgingival debridement using thin ultrasonic tips and additional instrumentation with Gracey mini-curettes, deliberately avoiding subgingival rinsing to support blood clot stabilization
Pockets associated with intrabony defects are filled with nano-HyA paste immediately after subgingival debridement
Eligibility Criteria
You may qualify if:
- Males and females aged ≥ 18 years.
- Patients with a diagnosis of periodontitis (stage II or III).
- At least one tooth with ≥5 mm PPD and CAL and evidence of radiographic bone loss.
- Presenting with at least 1 intrabony defect, with a radiographic intra-bony component ≥3 mm.
You may not qualify if:
- Patients with systemic diseases.
- Pregnant or lactating females.
- Tobacco smokers (≥ 10 cigarettes per day).
- Multi-rooted teeth with class II and class III furcation defects.
- Third molars.
- Teeth with grade III mobility.
- Peri-apical pathology and acute abscess.
- Non-surgical or surgical periodontal treatment in the past 12 months.
- Prolonged treatment with antibiotics or anti-inflammatory agents within 6 months before periodontal therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Dentistry, Cairo University
Cairo, Cairo Governorate, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master's student, Periodontology
Study Record Dates
First Submitted
May 11, 2026
First Posted
May 19, 2026
Study Start
July 15, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 29, 2026
Last Updated
May 19, 2026
Record last verified: 2026-05